The Weinberg Group, the leading FDA consultancy, is excited to announce the addition of Paul Eichholz to our leadership team. As Senior Vice President, Quality and Compliance, with oversight of all quality services including: GMP, GCP, GLP, REMS auditing, mock FDA inspections, and the assessment and implementation of quality systems, Paul is an excellent addition to the firm’s management team.
Paul served in the US Navy Nuclear Submarine program for more than a decade. Upon his retirement from the military, Mr. Eichholz began his journey in pharmaceuticals where he has spent the past 15 years running quality and compliance programs for a number of companies including: Wyeth, Akorn, Solvay, and KV Pharmaceuticals. In his most recent position, Paul worked as the Vice President of Quality Assurance and Regulatory Affairs for The Harvard Drug Group, L.L.C.
“Paul is a welcome addition to our leadership team as we expand GMP, GCP, and other quality offerings,” said Matthew Weinberg, CEO. “He has a track record of hands-on quality and compliance experience combined with significant program management expertise. We look forward to Paul’s leadership of our Quality Consulting Group.”
The Weinberg Group is the world’s preeminent FDA consulting firm. Obsessed with meeting our clients’ needs, we bring together in depth knowledge of science and regulation to consistently guide our clients to successful outcomes. We offer traditional regulatory and quality consulting, along with full outsourcing of regulatory affairs and quality services where we act as the regulatory or quality organization for our clients.